> BioCryst Pharmaceuticals of Birmingham, AL said that the FDA has given fast-track development status to Fodosine, its experimental drug for relapsed or refractory T-cell leukemia. Fodosine is in Phase IIa and reportedly features strong binding with a target enzyme. Release
> Global contract research organization i3 has acquired SKM Oncology and its related businesses. SKM is a full-service CRO and a leader in the delivery of oncology clinical trials in Germany. Release
> Japan's GNI is merging with China's Shanghai Genomics. Release
> India's Matrix Labs is buying Belgium's Docpharma - a sales and marketing operation - for $263 million. Release
> The FDA has approved Cornerstone BioPharma's pain medication, Balacet 325. Release
> Biotech startup iCeutica says it has closed its first round of venture capital. Release
> The FDA has extended its review of Solvay's sNDA for Aceon. Release
> Sweden's Karo Bio launched a Phase I trial of KB2115 for obesity. Release
> Skyepharma has gained Germany's approval for its drug to treat asthma and COPD. Report
And finally...Researchers say lifestyle changes could help people with a family history of Alzheimer's avoid the disease. Story